8 Defective Expression and DNA Variants of TGFBR 2 in Chinese Small Cell Lung Carcinoma

[1]  J. V. van Meerbeeck,et al.  Treatment of extensive-stage small cell lung carcinoma: current status and future prospects , 2010, European Respiratory Journal.

[2]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[3]  Xiaohong Liu,et al.  Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma. , 2007, Lung cancer.

[4]  P. Dijke,et al.  Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .

[5]  Qiang Huang,et al.  Novel microdeletion in the transforming growth factor β type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma , 2007, Genes, chromosomes & cancer.

[6]  C. Hill,et al.  Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. , 2006, Cytokine & growth factor reviews.

[7]  Gerard C Blobe,et al.  Role of transforming growth factor Beta in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. Yanagisawa,et al.  Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines. , 2001, Cancer research.

[9]  S. Khuder,et al.  Effect of smoking cessation on major histologic types of lung cancer. , 2001, Chest.

[10]  H. Kim,et al.  Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation. , 2000, Anticancer research.

[11]  Simpson,et al.  Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in‐situ and invasive carcinomas , 2000, Histopathology.

[12]  T. Wheeler,et al.  Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Yokota,et al.  Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. , 1997, Carcinogenesis.

[14]  M. Ohue,et al.  Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. , 1997, Cancer letters.

[15]  Y. Yatabe,et al.  Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. , 1996, Cancer research.

[16]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[17]  Mahlon D. Johnson,et al.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. , 1993, The Journal of clinical investigation.

[18]  R. Alexander,et al.  Effects of bombesin on growth of human small cell lung carcinoma in vivo. , 1988, Cancer research.

[19]  Kohei Miyazono,et al.  Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[20]  Renato Martins,et al.  Small cell lung cancer. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

[21]  A. Moustakas,et al.  Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. , 2007, Biochimica et biophysica acta.

[22]  S. Jakowlew.  Transforming growth factor-beta in cancer and metastasis. , 2006, Cancer metastasis reviews.

[23]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[24]  R. Seruca,et al.  Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas. , 2003, The Journal of pathology.

[25]  R. Derynck,et al.  TGF-beta signaling in cancer--a double-edged sword. , 2001, Trends in cell biology.

[26]  Y. Shim,et al.  Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. , 1999, Anticancer research.

[27]  M Reiss,et al.  Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. , 1997, Oncology research.

[28]  Y. Bang,et al.  Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. , 1997, Cancer research.

[29]  R C Brownson,et al.  Gender and histologic type variations in smoking-related risk of lung cancer. , 1992, Epidemiology.